Edwards Lifesciences Operating Margin 2006-2021 | EW

Current and historical operating margin for Edwards Lifesciences (EW) over the last 10 years. The current operating profit margin for Edwards Lifesciences as of June 30, 2021 is 28.03%.
Edwards Lifesciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2021-06-30 $4.93B $1.64B 33.19%
2021-03-31 $4.48B $0.92B 20.63%
2020-12-31 $4.39B $0.90B 20.45%
2020-09-30 $4.37B $0.86B 19.62%
2020-06-30 $4.32B $0.79B 18.35%
2020-03-31 $4.48B $1.23B 27.45%
2019-12-31 $4.35B $1.15B 26.38%
2019-09-30 $4.15B $0.83B 20.01%
2019-06-30 $3.97B $0.79B 19.82%
2019-03-31 $3.82B $0.77B 20.15%
2018-12-31 $3.72B $0.75B 20.11%
2018-09-30 $3.64B $1.06B 29.13%
2018-06-30 $3.55B $1.04B 29.24%
2018-03-31 $3.45B $1.04B 30.02%
2017-12-31 $3.44B $1.09B 31.74%
2017-09-30 $3.32B $0.96B 28.86%
2017-06-30 $3.23B $0.92B 28.58%
2017-03-31 $3.15B $0.89B 28.25%
2016-12-31 $2.96B $0.78B 26.43%
2016-09-30 $2.87B $0.79B 27.46%
2016-06-30 $2.74B $0.75B 27.27%
2016-03-31 $2.60B $0.68B 26.14%
2015-12-31 $2.49B $0.64B 25.78%
2015-09-30 $2.44B $0.62B 25.32%
2015-06-30 $2.43B $0.59B 24.34%
2015-03-31 $2.39B $0.56B 23.60%
2014-12-31 $2.32B $0.49B 21.23%
2014-09-30 $2.24B $0.47B 21.03%
2014-06-30 $2.13B $0.45B 21.00%
2014-03-31 $2.07B $0.46B 21.97%
2013-12-31 $2.05B $0.47B 23.12%
2013-09-30 $2.02B $0.49B 24.16%
2013-06-30 $1.97B $0.48B 24.19%
2013-03-31 $1.94B $0.45B 23.03%
2012-12-31 $1.90B $0.42B 22.12%
2012-09-30 $1.82B $0.36B 20.01%
2012-06-30 $1.78B $0.33B 18.44%
2012-03-31 $1.73B $0.31B 17.77%
2011-12-31 $1.68B $0.30B 17.87%
2011-09-30 $1.64B $0.29B 17.92%
2011-06-30 $1.58B $0.30B 19.09%
2011-03-31 $1.51B $0.30B 19.85%
2010-12-31 $1.45B $0.29B 19.70%
2010-09-30 $1.40B $0.27B 19.19%
2010-06-30 $1.38B $0.26B 18.78%
2010-03-31 $1.35B $0.25B 18.37%
2009-12-31 $1.32B $0.24B 18.07%
2009-09-30 $1.29B $0.23B 17.96%
2009-06-30 $1.26B $0.22B 17.17%
2009-03-31 $1.26B $0.21B 16.40%
2008-12-31 $1.24B $0.20B 15.98%
2008-09-30 $1.22B $0.19B 15.22%
2008-06-30 $1.18B $0.18B 15.27%
2008-03-31 $1.12B $0.18B 15.57%
2007-12-31 $1.09B $0.17B 15.86%
2007-09-30 $1.06B $0.17B 16.17%
2007-06-30 $1.05B $0.18B 16.67%
2007-03-31 $1.04B $0.17B 16.67%
2006-12-31 $1.04B $0.17B 16.78%
2006-09-30 $1.02B $0.18B 17.34%
2006-06-30 $1.02B $0.18B 17.34%
2006-03-31 $1.01B $0.18B 17.50%
2005-12-31 $1.00B $0.17B 17.43%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $74.843B $4.386B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $239.899B 23.88
ALCON INC (ALC) Switzerland $41.551B 46.01
STERIS (STE) Ireland $21.968B 33.37
Fresenius Medical Care AG KGaA (FMS) Germany $21.048B 14.72
Teleflex (TFX) United States $18.163B 31.71
Penumbra (PEN) United States $10.196B 290.34
Globus Medical (GMED) United States $8.194B 38.31
Nevro (NVRO) United States $4.191B 0.00
Integer Holdings (ITGR) United States $3.008B 28.05
Glaukos (GKOS) United States $2.356B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.517B 33.90
CryoLife (CRY) United States $0.913B 122.21